{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:35:51Z","timestamp":1768487751632,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T00:00:00Z","timestamp":1346112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s11064-012-0874-2","type":"journal-article","created":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T06:48:20Z","timestamp":1346050100000},"page":"2805-2813","source":"Crossref","is-referenced-by-count":38,"title":["Quantitative Proteomic Analysis of Human Substantia Nigra in Alzheimer\u2019s Disease, Huntington\u2019s Disease and Multiple Sclerosis"],"prefix":"10.1007","volume":"37","author":[{"given":"Sheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances Fangjia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Seeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,28]]},"reference":[{"issue":"12","key":"874_CR1","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1002\/pmic.200400848","volume":"4","author":"M Basso","year":"2004","unstructured":"Basso M, Giraudo S, Corpillo D, Bergamasco B, Lopiano L, Fasano M (2004) Proteome analysis of human substantia nigra in Parkinson\u2019s disease. Proteomics 4(12):3943\u20133952","journal-title":"Proteomics"},{"issue":"6","key":"874_CR2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/glia.440020605","volume":"2","author":"TG Beach","year":"1989","unstructured":"Beach TG, Walker R, McGeer EG (1989) Patterns of gliosis in Alzheimer\u2019s disease and aging cerebrum. Glia 2(6):420\u2013436","journal-title":"Glia"},{"issue":"1\u20132","key":"874_CR3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1432-1033.1994.tb19910.x","volume":"219","author":"J Becker","year":"1994","unstructured":"Becker J, Craig EA (1994) Heat-shock proteins as molecular chaperones. Eur J Biochem 219(1\u20132):11\u201323","journal-title":"Eur J Biochem"},{"issue":"3","key":"874_CR4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-7799(98)01245-1","volume":"17","author":"WP Blackstock","year":"1999","unstructured":"Blackstock WP, Weir MP (1999) Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol 17(3):121\u2013127","journal-title":"Trends Biotechnol"},{"key":"874_CR5","doi-asserted-by":"crossref","unstructured":"Cerione RA (2004) Cdc42: new roads to travel. Trends Cell Biol 14(3):127\u2013132","DOI":"10.1016\/j.tcb.2004.01.008"},{"issue":"1","key":"874_CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1379\/CSC-236R.1","volume":"12","author":"S Chen","year":"2007","unstructured":"Chen S, Brown IR (2007) Neuronal expression of constitutive heat shock proteins: implications for neurodegenerative diseases. Cell Stress Chaperones 12(1):51\u201358","journal-title":"Cell Stress Chaperones"},{"issue":"Pt 10","key":"874_CR7","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1242\/jcs.01171","volume":"117","author":"MK Dougherty","year":"2004","unstructured":"Dougherty MK, Morrison DK (2004) Unlocking the code of 14-3-3. J Cell Sci 117(Pt 10):1875\u20131884","journal-title":"J Cell Sci"},{"issue":"10","key":"874_CR8","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2174\/1389450111007011193","volume":"11","author":"IL Ferreira","year":"2010","unstructured":"Ferreira IL, Resende R, Ferreiro E, Rego AC, Pereira CF (2010) Multiple defects in energy metabolism in Alzheimer\u2019s disease. Curr Drug Targets 11(10):1193\u20131206","journal-title":"Curr Drug Targets"},{"issue":"2","key":"874_CR9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.52.2.193","volume":"52","author":"WR Gibb","year":"1989","unstructured":"Gibb WR, Mountjoy CQ, Mann DM, Lees AJ (1989) The substantia nigra and ventral tegmental area in Alzheimer\u2019s disease and Down\u2019s syndrome. J Neurol Neurosurg Psychiatry 52(2):193\u2013200","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"874_CR10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/13690","volume":"17","author":"SP Gygi","year":"1999","unstructured":"Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17(10):994\u2013999","journal-title":"Nat Biotechnol"},{"issue":"4","key":"874_CR11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1615\/CritRevNeurobiol.v11.i4.40","volume":"11","author":"SN Haber","year":"1997","unstructured":"Haber SN, Fudge JL (1997) The primate substantia nigra and VTA: integrative circuitry and function. Crit Rev Neurobiol 11(4):323\u2013342","journal-title":"Crit Rev Neurobiol"},{"issue":"3","key":"874_CR12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1212\/WNL.41.3.345","volume":"41","author":"JE Hamos","year":"1991","unstructured":"Hamos JE, Oblas B, Pulaski-Salo D, Welch WJ, Bole DG, Drachman DA (1991) Expression of heat shock proteins in Alzheimer\u2019s disease. Neurology 41(3):345\u2013350","journal-title":"Neurology"},{"issue":"1","key":"874_CR13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.mehy.2006.01.019","volume":"67","author":"K Kaneko","year":"2006","unstructured":"Kaneko K, Hachiya NS (2006) The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions. Med Hypotheses 67(1):169\u2013171","journal-title":"Med Hypotheses"},{"issue":"2","key":"874_CR14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1474-4422(10)70277-5","volume":"10","author":"D Kapogiannis","year":"2011","unstructured":"Kapogiannis D, Mattson MP (2011) Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer\u2019s disease. Lancet Neurol 10(2):187\u2013198","journal-title":"Lancet Neurol"},{"issue":"7\u20138","key":"874_CR15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbadis.2010.05.001","volume":"1802","author":"J Kim","year":"2010","unstructured":"Kim J, Amante DJ, Moody JP, Edgerly CK, Bordiuk OL, Smith K, Matson SA, Matson WR, Scherzer CR, Rosas HD, Hersch SM, Ferrante RJ (2010) Reduced creatine kinase as a central and peripheral biomarker in Huntington\u2019s disease. Biochim Biophys Acta 1802(7\u20138):673\u2013681","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"874_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(96)12598-2","volume":"209","author":"R Layfield","year":"1996","unstructured":"Layfield R, Fergusson J, Aitken A, Lowe J, Landon M, Mayer RJ (1996) Neurofibrillary tangles of Alzheimer\u2019s disease brains contain 14-3-3 proteins. Neurosci Lett 209(1):57\u201360","journal-title":"Neurosci Lett"},{"issue":"11","key":"874_CR17","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1073\/pnas.0709259105","volume":"105","author":"WS Liang","year":"2008","unstructured":"Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, Grover A, Niedzielko TL, Schneider LE, Mastroeni D, Caselli R, Kukull W, Morris JC, Hulette CM, Schmechel D, Rogers J, Stephan DA (2008) Alzheimer\u2019s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci USA 105(11):4441\u20134446","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"874_CR18","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1523\/JNEUROSCI.4330-03.2004","volume":"24","author":"J Magrane","year":"2004","unstructured":"Magrane J, Smith RC, Walsh K, Querfurth HW (2004) Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons. J Neurosci 24(7):1700\u20131706","journal-title":"J Neurosci"},{"issue":"25","key":"874_CR19","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1056\/NEJM199906243402507","volume":"340","author":"JB Martin","year":"1999","unstructured":"Martin JB (1999) Molecular basis of the neurodegenerative disorders. N Engl J Med 340(25):1970\u20131980","journal-title":"N Engl J Med"},{"issue":"12","key":"874_CR20","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1021\/pr200671d","volume":"10","author":"Y Meng","year":"2011","unstructured":"Meng Y, Liu F, Pang C, Fan S, Song M, Wang D, Li W, Yu S (2011) Label-free quantitative proteomics analysis of cotton leaf response to nitric oxide. J Proteome Res 10(12):5416\u20135432","journal-title":"J Proteome Res"},{"key":"874_CR21","first-page":"257","volume-title":"Multiple sclerosis","author":"GRW Moore","year":"1998","unstructured":"Moore GRW (1998) Neuropathology and pathophysiology of the multiple sclerosis lesion. In: Paty DW, Ebers GC (eds) Multiple sclerosis. F.A. Davis Company, Philadelphia, pp 257\u2013327"},{"issue":"1","key":"874_CR22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrn1587","volume":"6","author":"PJ Muchowski","year":"2005","unstructured":"Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6(1):11\u201322","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"874_CR23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2007.11.018","volume":"431","author":"K Omi","year":"2008","unstructured":"Omi K, Hachiya NS, Tanaka M, Tokunaga K, Kaneko K (2008) 14-3-3 zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein. Neurosci Lett 431(1):45\u201350","journal-title":"Neurosci Lett"},{"issue":"5","key":"874_CR24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1074\/mcp.M200025-MCP200","volume":"1","author":"SE Ong","year":"2002","unstructured":"Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1(5):376\u2013386","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"874_CR25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1389-0344(01)00095-8","volume":"18","author":"SE Ong","year":"2001","unstructured":"Ong SE, Pandey A (2001) An evaluation of the use of two-dimensional gel electrophoresis in proteomics. Biomol Eng 18(5):195\u2013205","journal-title":"Biomol Eng"},{"issue":"1","key":"874_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.410260103","volume":"26","author":"K Oyanagi","year":"1989","unstructured":"Oyanagi K, Takeda S, Takahashi H, Ohama E, Ikuta F (1989) A quantitative investigation of the substantia nigra in Huntington\u2019s disease. Ann Neurol 26(1):13\u201319","journal-title":"Ann Neurol"},{"issue":"1","key":"874_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jprot.2007.12.001","volume":"71","author":"A Panchaud","year":"2008","unstructured":"Panchaud A, Affolter M, Moreillon P, Kussmann M (2008) Experimental and computational approaches to quantitative proteomics: status quo and outlook. J Proteomics 71(1):19\u201333","journal-title":"J Proteomics"},{"issue":"3\u20134","key":"874_CR28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0169-328X(91)90033-T","volume":"11","author":"N Perez","year":"1991","unstructured":"Perez N, Sugar J, Charya S, Johnson G, Merril C, Bierer L, Perl D, Haroutunian V, Wallace W (1991) Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer\u2019s disease. Brain Res Mol Brain Res 11(3\u20134):249\u2013254","journal-title":"Brain Res Mol Brain Res"},{"issue":"12","key":"874_CR29","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","volume":"4","author":"M Perluigi","year":"2005","unstructured":"Perluigi M, Poon HF, Maragos W, Pierce WM, Klein JB, Calabrese V, Cini C, De Marco C, Butterfield DA (2005) Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: a model of Huntington disease. Mol Cell Proteomics 4(12):1849\u20131861","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"874_CR30","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1074\/mcp.M400129-MCP200","volume":"3","author":"PL Ross","year":"2004","unstructured":"Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3(12):1154\u20131169","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"874_CR31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.291.3.358","volume":"291","author":"AH Schapira","year":"2004","unstructured":"Schapira AH, Olanow CW (2004) Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions. JAMA 291(3):358\u2013364","journal-title":"JAMA"},{"issue":"1","key":"874_CR32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1074\/mcp.M500230-MCP200","volume":"5","author":"JC Silva","year":"2006","unstructured":"Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ (2006) Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics 5(1):144\u2013156","journal-title":"Mol Cell Proteomics"},{"key":"874_CR33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0079-6123(06)60011-3","volume":"160","author":"JM Tepper","year":"2007","unstructured":"Tepper JM, Lee CR (2007) GABAergic control of substantia nigra dopaminergic neurons. Prog Brain Res 160:189\u2013208","journal-title":"Prog Brain Res"},{"key":"874_CR34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","volume":"31","author":"BD Trapp","year":"2008","unstructured":"Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247\u2013269","journal-title":"Annu Rev Neurosci"},{"issue":"5","key":"874_CR35","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1074\/mcp.M600303-MCP200","volume":"6","author":"JP Vissers","year":"2007","unstructured":"Vissers JP, Langridge JI, Aerts JM (2007) Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease. Mol Cell Proteomics 6(5):755\u2013766","journal-title":"Mol Cell Proteomics"},{"issue":"9557","key":"874_CR36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369(9557):218\u2013228","journal-title":"Lancet"},{"issue":"9431","key":"874_CR37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(04)16739-1","volume":"364","author":"FO Walker","year":"2004","unstructured":"Walker FO, Raymond LA (2004) Targeting energy metabolism in Huntington\u2019s disease. Lancet 364(9431):312\u2013313","journal-title":"Lancet"},{"issue":"13","key":"874_CR38","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1212\/WNL.0b013e3181b8a9f8","volume":"73","author":"U Walter","year":"2009","unstructured":"Walter U, Wagner S, Horowski S, Benecke R, Zettl UK (2009) Transcranial brain sonography findings predict disease progression in multiple sclerosis. Neurology 73(13):1010\u20131017","journal-title":"Neurology"},{"issue":"3","key":"874_CR39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/85686","volume":"19","author":"MP Washburn","year":"2001","unstructured":"Washburn MP, Wolters D, Yates JR 3rd (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19(3):242\u2013247","journal-title":"Nat Biotechnol"},{"key":"874_CR40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-5956-6-8","volume":"6","author":"CJ Werner","year":"2008","unstructured":"Werner CJ, Heyny-von Haussen R, Mall G, Wolf S (2008) Proteome analysis of human substantia nigra in Parkinson\u2019s disease. Proteome Sci 6:8","journal-title":"Proteome Sci"},{"issue":"2","key":"874_CR41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ana.1077","volume":"50","author":"P Werner","year":"2001","unstructured":"Werner P, Pitt D, Raine CS (2001) Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50(2):169\u2013180","journal-title":"Ann Neurol"},{"issue":"13","key":"874_CR42","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1021\/ac001404c","volume":"73","author":"X Yao","year":"2001","unstructured":"Yao X, Freas A, Ramirez J, Demirev PA, Fenselau C (2001) Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal Chem 73(13):2836\u20132842","journal-title":"Anal Chem"},{"issue":"5","key":"874_CR43","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s13238-011-1049-7","volume":"2","author":"C Zhang","year":"2011","unstructured":"Zhang C, Liu Y, Hu Z, An L, He Y, Hang H (2011) Targeted deletion of mouse Rad1 leads to deficient cellular DNA damage responses. Protein Cell 2(5):410\u2013422","journal-title":"Protein Cell"},{"issue":"12","key":"874_CR44","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/prca.200700077","volume":"1","author":"X Zhao","year":"2007","unstructured":"Zhao X, Li Q, Zhao L, Pu X (2007) Proteome analysis of substantia nigra and striatal tissue in the mouse MPTP model of Parkinson\u2019s disease. Proteomics Clin Appl 1(12):1559\u20131569","journal-title":"Proteomics Clin Appl"},{"key":"874_CR45","doi-asserted-by":"crossref","unstructured":"Zhu X, Raina AK, Boux H, Simmons ZL, Takeda A, Smith MA (2000) Activation of oncogenic pathways in degenerating neurons in Alzheimer disease. Int J Dev Neurosci 18(4\u20135):433\u2013437","DOI":"10.1016\/S0736-5748(00)00010-1"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-012-0874-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-012-0874-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-012-0874-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:34:46Z","timestamp":1559349286000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-012-0874-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,28]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["874"],"URL":"https:\/\/doi.org\/10.1007\/s11064-012-0874-2","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,28]]}}}